Trials / Unknown
UnknownNCT01394432
"ESTIMATION Study" for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction
Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesised that endocardial stem cells implantation following after percutaneous coronary intervention (PCI) could reduce the scar formation and increase reverse remodeling in patients with primary acute myocardial infarction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PCI and Stem Cells or Placebo injections | Conventional percutaneous coronary intervention after acute myocardial infarction. Harvest of bone marrow from iliac crest. Mesenchymal autologous stem cells preparation (7-10 days after PCI). LV mapping with Noga system (7-10 days after PCI). Randomization 1:1. Stem Cells or placebo implantation. |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-11-01
- Completion
- 2016-11-01
- First posted
- 2011-07-14
- Last updated
- 2015-09-23
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT01394432. Inclusion in this directory is not an endorsement.